Cargando…

HSulf-1 and palbociclib exert synergistic antitumor effects on RB-positive triple-negative breast cancer

Human sulfatase-1 (HSulf-1) is emerging as a novel prognostic biomarker in breast cancer. Previous studies demonstrated HSulf-1 to function as a negative regulator of cyclin D1 in breast cancer. Accumulating preclinical evidence is supporting the efficacy of cyclin-dependent kinase (CDK) 4/6 inhibit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Fengxia, Zhang, Zhicai, Yu, Yihan, Liu, Qiuyu, Pu, Feifei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2020
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7252455/ https://www.ncbi.nlm.nih.gov/pubmed/32377705 http://dx.doi.org/10.3892/ijo.2020.5057

Ejemplares similares

Combination of palbociclib with enzalutamide shows in vitro activity in RB proficient and androgen receptor positive triple negative breast cancer cells
por: Liu, Chun-Yu, et al.
Publicado: (2017)

Novel sequential treatment with palbociclib enhances the effect of cisplatin in RB-proficient triple-negative breast cancer
por: Huang, Yajing, et al.
Publicado: (2020)

Mass spectrometry analysis of the human endosulfatase Hsulf-2
por: Seffouh, Ilham, et al.
Publicado: (2019)

KPT‐330 and Y219 exert a synergistic antitumor effect in triple‐negative breast cancer through inhibiting NF‐κB signaling
por: Wen, Tiantian, et al.
Publicado: (2023)

A Screened GPR1 Peptide Exerts Antitumor Effects on Triple-Negative Breast Cancer
por: Huang, Chen, et al.
Publicado: (2020)

Role of postmastectomy radiotherapy in early-stage (T1–2N0–1M0) triple-negative breast cancer: a systematic review
por: Chen, Fengxia, et al.
Publicado: (2017)

The CDK4/6 Inhibitor Palbociclib Inhibits Estrogen-Positive and Triple Negative Breast Cancer Bone Metastasis In Vivo
por: Saleh, Lubaid, et al.
Publicado: (2023)

Dezocine, An Opioid Analgesic, Exerts Antitumor Effects in Triple-Negative Breast Cancer by Targeting Nicotinamide Phosphoribosyltransferase
por: Xue, Chenyang, et al.
Publicado: (2021)

Cyclin E1 and Rb modulation as common events at time of resistance to palbociclib in hormone receptor-positive breast cancer
por: Guarducci, Cristina, et al.
Publicado: (2018)

GLUT1 inhibition blocks growth of RB1-positive triple negative breast cancer
por: Wu, Qin, et al.
Publicado: (2020)

Loss of HSulf-1 promotes altered lipid metabolism in ovarian cancer
por: Roy, Debarshi, et al.
Publicado: (2014)

Synergistic antitumor effects of S-1 with eribulin in vitro and in vivo for triple-negative breast cancer cell lines
por: Terashima, Masato, et al.
Publicado: (2014)

hSulf-1 Gene Exhibits Anticancer Efficacy through Negatively Regulating VEGFR-2 Signaling in Human Cancers
por: Ji, Weidan, et al.
Publicado: (2011)

Erratum to: Loss of HSulf-1 promotes altered lipid metabolism in ovarian cancer
por: Roy, Debarshi, et al.
Publicado: (2014)

The synergistic anticancer effect of cisplatin combined with Oldenlandia diffusa in osteosarcoma MG-63 cell line in vitro
por: Pu, Feifei, et al.
Publicado: (2016)

Role of stanniocalcin-1 in breast cancer
por: Chen, Fengxia, et al.
Publicado: (2019)

Ruxolitinib with resminostat exert synergistic antitumor effects in Cutaneous T-cell Lymphoma
por: Karagianni, Fani, et al.
Publicado: (2021)

Glycomics Analysis of Mammalian Heparan Sulfates Modified by the Human Extracellular Sulfatase HSulf2
por: Staples, Gregory O., et al.
Publicado: (2011)

Loss of HSulf-1: The Missing Link between Autophagy and Lipid Droplets in Ovarian Cancer
por: Roy, Debarshi, et al.
Publicado: (2017)

Combined Use of Emodin and Ginsenoside Rb1 Exerts Synergistic Neuroprotection in Cerebral Ischemia/Reperfusion Rats
por: Li, Yan, et al.
Publicado: (2018)

BETi enhance ATGL expression and its lipase activity to exert their antitumoral effects in triple-negative breast cancer (TNBC) cells
por: Rossi, Teresa, et al.
Publicado: (2023)

Two Novel Palbociclib-Resorcinol and Palbociclib-Orcinol Cocrystals with Enhanced Solubility and Dissolution Rate
por: Duan, Chenxin, et al.
Publicado: (2021)

Clinical efficacy of customized modular prosthesis in the treatment of femoral shaft metastases
por: Pu, Feifei, et al.
Publicado: (2023)

Clinical effect of surgical resection on primary malignant and invasive bone tumours of the proximal fibula
por: Pu, Feifei, et al.
Publicado: (2023)

Enhanced levels of Hsulf-1 interfere with heparin-binding growth factor signaling in pancreatic cancer
por: Li, Junsheng, et al.
Publicado: (2005)

HSulf-1 deficiency dictates a metabolic reprograming of glycolysis and TCA cycle in ovarian cancer
por: Mondal, Susmita, et al.
Publicado: (2015)

LPM3770277, a Potent Novel CDK4/6 Degrader, Exerts Antitumor Effect Against Triple-Negative Breast Cancer
por: Qiu, Jiahao, et al.
Publicado: (2022)

Domperidone Exerts Antitumor Activity in Triple-Negative Breast Cancer Cells by Modulating Reactive Oxygen Species and JAK/STAT3 Signaling
por: Shakya, Rajina, et al.
Publicado: (2023)

Synergistic antitumor effects of circularly permuted TRAIL with doxorubicin in triple-negative breast cancer: Circularly permuted TRAIL with Dox in TNBC
por: Liu, Jia, et al.
Publicado: (2023)

CDK4/6 and autophagy inhibitors synergistically induce senescence in Rb positive cytoplasmic cyclin E negative cancers
por: Vijayaraghavan, Smruthi, et al.
Publicado: (2017)

The nature of triple-negative breast cancer classification and antitumoral strategies
por: Kim, Songmi, et al.
Publicado: (2020)

Palbociclib Induces the Apoptosis of Lung Squamous Cell Carcinoma Cells via RB-Independent STAT3 Phosphorylation
por: Xiang, Wenjing, et al.
Publicado: (2022)

Identification of highly penetrant Rb-related synthetic lethal interactions in triple negative breast cancer
por: Brough, Rachel, et al.
Publicado: (2018)

MYC status as a determinant of synergistic response to Olaparib and Palbociclib in ovarian cancer
por: Yi, Jingyan, et al.
Publicado: (2019)

Overexpression of miRNA-3613-3p Enhances the Sensitivity of Triple Negative Breast Cancer to CDK4/6 Inhibitor Palbociclib
por: Yu, Yuanhang, et al.
Publicado: (2020)

Nifuroxazide boosts the anticancer efficacy of palbociclib-induced senescence by dual inhibition of STAT3 and CDK2 in triple-negative breast cancer
por: Wang, Xianzhe, et al.
Publicado: (2023)

Real life efficacy of palbociclib and endocrine therapy in HR positive, HER2 negative advanced breast cancer
por: Porte, B., et al.
Publicado: (2020)

Longitudinal multi-omics study of palbociclib resistance in HR-positive/HER2-negative metastatic breast cancer
por: Park, Yeon Hee, et al.
Publicado: (2023)

Capsaicin exerts synergistic antitumor effect with sorafenib in hepatocellular carcinoma cells through AMPK activation
por: Bort, Alicia, et al.
Publicado: (2017)

HSULF-1 inhibits ERK and AKT signaling and decreases cell viability in vitro in human lung epithelial cells
por: Zhang, Huiying, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_5bhvf2qn8v7d9268l26r784stq